Bad Blood reads like a West Coast version of All the President's Men.' - The New York Times 'Carreyrou tells the story virtually to perfection. Were it not for their courage, Theranos might still be testing blood today' - David Crow, The Financial Times The real heroes, though, are his sources: the young scientists who worked at the company and risked their reputations and careers by voicing their concerns. unmasking of Theranos is a tale of David and Goliath. a blistering critique of Silicon Valley, a kind of nonfiction corollary to Dave Eggers's The Circle. compelling. You will not be able to put this book down.' - The Washington Post It is a tale of heroic cupidity on a scale that made the very best and the very brightest look like the very, very foolish. 'A dazzling story of deception in Silicon Valley.

Publisher: Pan Macmillan ISBN: 9781509868087 Number of pages: 352 Weight: 264 g Dimensions: 196 x 129 x 24 mm MEDIA REVIEWS In Bad Blood, John Carreyrou tells the riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley.

There was just one problem: The technology didn't work. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes's worth at an estimated $4.7 billion. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup 'unicorn' promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. The full inside story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup, by the prize-winning journalist who first broke the story and pursued it to the end, despite pressure from its charismatic CEO and threats by her lawyers. Winner of the Financial Times and McKinsey Business Book of the Year Award 2018

Bad blood secrets and lies